Fig. 4.
In multivariable Cox models (A and B), including cyclin B1 protein expression, tumor stage, grade and patient age, high primary tumor cyclin B1 protein expression assessed as a continuous variable by RPPA was a significant predictor of hormone receptor–positive breast tumor recurrence and patient death in 195 patients treated only with adjuvant tamoxifen after definitive locoregional therapy.